A recent FDA Advisory Committee vote could allow researchers to use continuous glucose monitoring (CGM) systems in place of traditional methods, providing “a myriad of customized data,” says Quintiles.
Although obesity dramatically increases the risk of developing Type
II diabetes, nobody knew why until researchers found a protein that
links the two diseases, opening up the possibility of developing
drugs that prevent diabetes.
The Servier Institute and Pasteur-Weizmann Council has awarded its
annual prize in biomedical research to two scientists for their
work in diabetes and autoimmunity, paving the way for improved
treatment and an eventual cure for this...
New diabetes trials scheduled to start this spring have been
heralded as groundbreaking as researchers aim to reverse juvenile
diabetes of which numbers have been steadily on the rise in
Biotechnology company, Amgen, and Biovitrum have expanded its
existing license agreement for its treatment of metabolic
disorders, focusing on type 2 diabetes, which currently afflicts
over 160 million people worldwide.
New insights into the dysregulation of beta cells and their impact
on type 2 diabetes progression is now possible after Roche
announced a partnership, which aims to identify novel pathways and
new biomarkers for drug development.
Researchers are developing breakthrough diabetes drugs that use
modified forms of a naturally occurring molecule produced by the
body. The approach characterises the major investments by the
biopharmaceutical industry to develop and...